Pangenotypic therapies glecaprevir-pibrentasvir (G-P) and sofosbuvir-velpatasvir-voxilaprevir (S-V-V) after failure with interferon (IFN)-free direct-acting antiviral (DAA) treatment for hepatitis C
- Resource Type
- Source
- Journal of Hepatology. 73:S846-S847
- Subject
Hepatology - Language
- ISSN
- 0168-8278